The host response to herpes simplex virus infection

Current Opinion in Infectious Diseases

Volumn 17, Issue 3, 2004, Pages 199-203

  Pollara, Gabriele ^a   Katz, David R ^a   Chain, Benjamin M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dendritic cells; Herpes simplex virus; Type I interferon; Vaccination

Indexed keywords

DNA VACCINE; HERPES SIMPLEX VACCINE;

CELLULAR IMMUNITY; CLINICAL TRIAL; DENDRITIC CELL; HERPES; HERPES SIMPLEX VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION;

DENDRITIC CELLS; DRUG DESIGN; HERPES SIMPLEX; HERPESVIRUS VACCINES; HUMANS; INTERFERON TYPE I; SIMPLEXVIRUS;

EID: 2542619026     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200406000-00005     Document Type: Review

References (48)

1. Koelle DM, Corey L. Recent progress in herpes simplex virus immunobiology and vaccine research. Clin Microbiol Rev 2003; 16:96-113. This is an extensive and comprehensive review of the immunological response to HSV infection, and analyses how this knowledge is being used to design vaccines.
2. Schacker T, Zeh J, Hu HL, et al. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis 1998; 178:1616-1622.
3. Pereira RA, Scalzo A, Simmons A. Cutting edge: a NK complex-linked locus governs acute versus latent herpes simplex virus infection of neurons. J Immunol 2001; 166:5869-5873.
4. Grubor-Bauk B, Simmons A, Mayrhofer G, Speck PG. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. J Immunol 2003; 170:1430-1434.
5. Verschoor A, Brockman MA, Gadjeva M, et al. Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. J Immunol 2003; 171:5363-5371.
6. Mikloska Z, Sanna PP, Cunningham AL. Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro. J Virol 1999; 73:5934-5944.
7. van Lint A, Ayers M, Brooks AG, et al. Herpes simplex virus-specific CD8+ T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J Immunol 2004; 172:392-397. This study develops the concept that CD8 T cells are important in the control of HSV-1 infection both in the periphery and the nervous system, but at appropriate times after infection.
8. Mueller SN, Jones CM, Smith CM, et al. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J Exp Med 2002; 195:651-656.
9. ••].
10. ••] support the notion that HSV-1 latency is not immunologically neutral. Rather there is direct evidence for a chronic immune reaction, which can influence reactivation.
11. Wollenberg A, Wagner M, Gunther S, et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 2002; 119:1096-1102.
12. Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999; 284:1835-1837.
13. Iyoda T, Shimoyama S, Liu K, et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 2002; 195:1289-1302.
14. Schulz O, Reis e Sousa C. Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 2002; 107:183-189.
15. Vollstedt S, Franchini M, Hefti HP, et al. Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections. J Exp Med 2003; 197:575-584. This study demonstrates a correlation between the control of HSV infection and the number of DCs that can encounter the virus.
16. Salio M, Cella M, Suter M, Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 1999; 29:3245-3253.
17. Pollara G, Speidel K, Samady L, et al. Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. J Infect Dis 2003; 187:165-178. This study details the functional inhibition of DCs by HSV-1, but also demonstrates that paracrine crosstalk to uninfected DCs is an important mechanism to bypass this block in antigen presentation.
18. Jones CA, Fernandez M, Herc K, et al. Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro. J Virol 2003; 77:11139-11149.
19. Neumann J, Eis-Hubinger AM, Koch N. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion. J Immunol 2003; 171:3075-3083. This study demonstrates that HSV-1 infection can disrupt MHC class II loading as well as MHC class I.
20. ••].
21. ••] address the potential role of different DC subsets in the induction of immunity to HSV-1. Both exclude the roles of LCs and PDCs but propose disparate roles for CD8α+ and CD11b+ DCs in the activation of CD8 and CD4 T cells.
22. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392:86-89.
23. Smith CM, Belz GT, Wilson NS, et al. Cutting edge: conventional CD8{alpha}+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J Immunol 2003; 170:4437-4440.
24. Pooley JL, Heath WR, Shortman K. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CDB T cells by CD8+ dendritic cells. J Immunol 2001; 166:5327-5330.
25. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002; 2:151-161.
26. Moron G, Rueda P, Casal I, Leclerc C. CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules. J Exp Med 2002; 195:1233-1245.
27. Sprecher E, Becker Y. Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity. Arch Virol 1989; 107:191-205.
28. Lund J, Sato A, Akira S, et al. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198:513-520. This study demonstrates that the hypomethylated CpG motifs in HSV DNA can be recognized by the innate immune system through Toll-like receptor 9.
29. ••], this study shows that Toll-like receptor 9 recognition of HSV DNA is not critical in the resolution of cutaneous HSV infection.
30. Krug A, Veeraswamy R, Pekosz A, et al. Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J Exp Med 2003; 197:899-906.
31. Lebre MC, Antons JC, Kalinski P, et al. Double-stranded RNA-exposed human keratinocytes promote Th1 responses by inducing a type-1 polarized phenotype in dendritic cells: role of keratinocyte-derived tumor necrosis factor alpha, type I interferons, and interleukin-18. J Invest Dermatol 2003; 120:990-997.
32. Luft T, Luetjens P, Hochrein H, et al. IFN-α enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int Immunol 2002; 14:367-380.
33. Padovan E, Spagnoli GC, Ferrantini M, Heberer M. IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. J Leukoc Biol 2002; 71:669-676.
34. Lundberg P, Welander P, Han X, Cantin E. Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo. J Virol 2003; 77:11158-11169.
35. Youssef R, Shaker O, Sobeih S, et al. Detection of herpes simplex virus DNA in serum and oral secretions during acute recurrent herpes labialis. J Dermatol 2002; 29:404-410.
36. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999; 5:919-923.
37. •].
38. •] demonstrate the importance in vivo of type I IFN paracrine activity between DC subsets, enhancing both DC maturation and the cross-priming of T cells.
39. Hawiger D, Inaba K, Dorsett Y, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194:769-779.
40. Corey L, Langenberg AG, Ashley R, et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA 1999; 282:331-340.
41. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652-1661.
42. Lundberg P, Welander P, Openshaw H, et al. A locus on mouse chromosome 6 that determines resistance to herpes simplex virus also influences reactivation, while an unlinked locus augments resistance of female mice. J Virol 2003; 77:11661-11673.
43. Bourne N, Bravo FJ, Francotte M, et al. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs. J Infect Dis 2003; 187:542-549.
44. Harandi AM, Eriksson K, Holmgren J. A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J Virol 2003; 77:953-962.
45. Lee S, Gierynska M, Eo SK, et al. Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus. Microbes Infect 2003; 5:571-578.
46. Lee Y, Eo SK, Rouse RJ, Rouse BT. Influence of CCR7 ligand DNA preexposure on the magnitude and duration of immunity. Virology 2003; 312:169-180.
47. Toka FN, Gierynska M, Rouse BT. Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1. J Virol 2003; 77:12742-12752. This study documents that DNA vaccination with genes that can amplify antigen presentation in an inflammatory environment can enhance protective immune responses against HSV-1.
48. Suvas S, Kumaraguru U, Pack CD, et al. CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 2003; 198:889-901.